Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report

被引:33
作者
Inuzuka, Tadashi [1 ]
Nishikawa, Hiroki
Sekikawa, Akira
Takeda, Haruhiko
Henmi, Shinichiro
Sakamoto, Azusa
Saito, Sumio
Kita, Ryuichi
Kimura, Toru
Osaki, Yukio
Kudo, Masatoshi [2 ]
机构
[1] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennouji Ku, Osaka 5438555, Japan
[2] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan
关键词
Hepatocellular carcinoma; Sorafenib; Hepatic necrosis; Lung metastasis; Complete response; COMPLETE REMISSION; SYSTEMIC THERAPY; CANCER;
D O I
10.1159/000333279
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sorafenib, an oral multikinase inhibitor, has demonstrated clinical efficacy in patients with advanced hepatocellular carcinoma (HCC). However, in the SHARP trial (Sorafenib HCC Assessment Randomized Protocol trial) and the Asia-Pacific trial (conducted in the Asia-Pacific region), no cases of complete response (CR) were reported. Thereafter, only a relatively small number of CR cases were reported worldwide for sorafenib therapy. We herein report a case of CR in a patient treated with sorafenib for 4 months. The patient had advanced HCC with multiple lung metastases, and there has been no recurrence after 8 months following cessation of administration. To our knowledge, this is the first time a female treated with sorafenib alone for HCC has had a CR. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:152 / 157
页数:6
相关论文
共 14 条
[1]  
Chelis L, 2010, MED ONCOL
[2]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[3]   Complete Histologic Response Induced by Sorafenib in Advanced Hepatocellular Carcinoma: A Case Report [J].
Curtit, Elsa ;
Thiery-Vuillemin, Antoine ;
Nguyen, Thierry ;
Heyd, Bruno ;
Pivot, Xavier ;
Di Martino, Vincent ;
Borg, Christophe .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :E330-E332
[4]   Complete regression induced by sorafenib of locally advanced HCC allowing curative resection [J].
Irtan, Sabine ;
Chopin-Laly, Xavier ;
Ronot, Maxime ;
Faivre, Sandrine ;
Paradis, Valerie ;
Belghiti, Jacques .
LIVER INTERNATIONAL, 2011, 31 (05) :740-743
[5]   Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan [J].
Kudo, Masatoshi ;
Ueshima, Kazuomi .
ONCOLOGY, 2010, 78 :154-166
[6]   Sorafenib in advanced hepatocellular carcinoma [J].
Llovet, Josep M. ;
Ricci, Sergio ;
Mazzaferro, Vincenzo ;
Hilgard, Philip ;
Gane, Edward ;
Blanc, Jean-Frederic ;
Cosme de Oliveira, Andre ;
Santoro, Armando ;
Raoul, Jean-Luc ;
Forner, Alejandro ;
Schwartz, Myron ;
Porta, Camillo ;
Zeuzem, Stefan ;
Bolondi, Luigi ;
Greten, Tim F. ;
Galle, Peter R. ;
Seitz, Jean-Francois ;
Borbath, Ivan ;
Haussinger, Dieter ;
Giannaris, Tom ;
Shan, Minghua ;
Moscovici, Marius ;
Voliotis, Dimitris ;
Bruix, Jordi .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390
[7]   Systemic therapy for advanced hepatocellular carcinoma: a review [J].
Nowak, AK ;
Chow, PKH ;
Findlay, M .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) :1474-1484
[8]   Global cancer statistics, 2002 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108
[9]   Complete response for advanced liver cancer during sorafenib therapy: Case Report [J].
Sacco, Rodolfo ;
Bargellini, Irene ;
Gianluigi, Giannelli ;
Bertini, Marco ;
Bozzi, Elena ;
Altomare, Emanuele ;
Battaglia, Valentina ;
Romano, Antonio ;
Bertoni, Michele ;
Capria, Alfonso ;
Bresci, Giampaolo ;
Bartolozzi, Carlo .
BMC GASTROENTEROLOGY, 2011, 11
[10]   Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular Carcinoma [J].
Shao, Yu-Yun ;
Lin, Zhong-Zhe ;
Hsu, Chiun ;
Shen, Ying-Chun ;
Hsu, Chih-Hung ;
Cheng, Ann-Lii .
CANCER, 2010, 116 (19) :4590-4596